News & Updates

Vaccines are safe and effective in patients with autoimmune inflammatory rheumatic disease (AIIRD), according to several physicians who participated in a recent international survey. However, many of the respondents are also responsible for not encouraging their patients to get vaccinated.

Whole grain consumption, instead of refined grains, provides a protective benefit against coronary heart disease (CHD), cardiovascular disease (CVD), and all-cause mortality, suggests a study.

Sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) confer the greatest reduction in kidney and cardiovascular risks in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), according to a study.

The use of pembrolizumab in the neoadjuvant setting appears to be associated with a higher rate of downstaging and a survival advantage among patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based neoadjuvant chemotherapy, according to a study presented at this year’s ASCO Genitourinary Cancers Symposium.

First-line treatment of advanced renal cell carcinoma (aRCC) with nivolumab plus cabozantinib (N+C) results in sustained survival and response benefits at 3 years minimum follow-up, which is consistent with previous follow-ups, according to a study presented at the 2023 ASCO GU Cancers Symposium.